LFMD

NASDAQ Healthcare

LifeMD, Inc. - Common Stock

Health Information Services

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

๐Ÿ“Š Market Data
Price$5.00
Volume1,142,592
Market Cap236.72M
Beta1.770
RSI (14-Day)68.1
200-Day MA$5.05
50-Day MA$3.77
52-Week High$15.84
52-Week Low$2.56
Forward P/E11.24
Price / Book10.08
๐ŸŽฏ Investment Strategy Scores

LFMD scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 80/100โ–ผ -3
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 38/100โ–ผ -16
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 79/100โ–ฒ +9
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿš€ Moon Shot (80/100) โ€” this strategy High growth potential (high beta + oversold).

Lowest fit among scored strategies: ๐Ÿ‹ Institutional Whale (4/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find LFMD in your text

Paste any article, transcript, or post โ€” the tool will extract LFMD and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.